Renovaro Biosciences (RENB) Provides Update to Definitive Agreement with Predictive Oncology (POAI)

Go back to Renovaro Biosciences (RENB) Provides Update to Definitive Agreement with Predictive Oncology (POAI)

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

April 4, 2025 9:40 AM EDT

LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update regarding its Definitive Agreement with Predictive Oncology Predictive Oncology, Inc. (NASDAQ:... More